Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Castellanos

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Surgery|November 4, 2022
Discrepancies in survival after conversion to open in minimally invasive pancreatoduodenectomyAnthony M Villano, Karen Ruth, Jason Castellanos, et al.
Oncotarget|November 22, 2017
Adiponectin receptor agonists inhibit leptin induced pSTAT3 and <i>in vivo</i> pancreatic tumor growthFanuel Messaggio, Alisha M Mendonsa, Jason Castellanos, et al.
Cancer Research|September 21, 2018
Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic CancerSupriya Srinivasan, Tulasigeri Totiger, Chanjuan Shi, et al.
Molecular Cancer Therapeutics|November 9, 2018
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic CancerTulasigeri M Totiger, Supriya Srinivasan, Venkatakrishna R Jala, et al.
Annals of Surgery|July 24, 2024
A Randomized, Controlled Trial Evaluating Perioperative Risk-stratification and Risk-based, Protocol-driven Management After Elective Major Cancer SurgeryNestor F Esnaola, Raju Chelluri, Jason Castellanos, et al.
Journal of the American College of Surgeons|May 30, 2009
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?Nipun B Merchant, Jennifer Rymer, Elizabeth A S Koehler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023Al B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAl B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Surgery|November 4, 2022
Discrepancies in survival after conversion to open in minimally invasive pancreatoduodenectomyAnthony M Villano, Karen Ruth, Jason Castellanos, et al.
Oncotarget|November 22, 2017
Adiponectin receptor agonists inhibit leptin induced pSTAT3 and <i>in vivo</i> pancreatic tumor growthFanuel Messaggio, Alisha M Mendonsa, Jason Castellanos, et al.
Cancer Research|September 21, 2018
Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic CancerSupriya Srinivasan, Tulasigeri Totiger, Chanjuan Shi, et al.
Molecular Cancer Therapeutics|November 9, 2018
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic CancerTulasigeri M Totiger, Supriya Srinivasan, Venkatakrishna R Jala, et al.
Annals of Surgery|July 24, 2024
A Randomized, Controlled Trial Evaluating Perioperative Risk-stratification and Risk-based, Protocol-driven Management After Elective Major Cancer SurgeryNestor F Esnaola, Raju Chelluri, Jason Castellanos, et al.
Journal of the American College of Surgeons|May 30, 2009
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?Nipun B Merchant, Jennifer Rymer, Elizabeth A S Koehler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023Al B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAl B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Pageof 1